| Title |
Good practice in antibiotic use: what about linezolid in a French university hospital?
|
|---|---|
| Published in |
International Journal of Clinical Pharmacy, November 2011
|
| DOI | 10.1007/s11096-011-9576-0 |
| Pubmed ID | |
| Authors |
Guillaume Aubin, Christine Lebland, Stéphane Corvec, Patrick Thomaré, Gilles Potel, Jocelyne Caillon, Dominique Navas |
| Abstract |
Linezolid represents an important advance in the treatment of methicillinresistant staphylococci. Its effectiveness should be preserved by appropriate uses. The aims of this survey were to describe the use of linezolid in clinical practice and to assess its overall safety. |
Mendeley readers
The data shown below were compiled from readership statistics for 30 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Iran, Islamic Republic of | 1 | 3% |
| Unknown | 29 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 5 | 17% |
| Researcher | 5 | 17% |
| Other | 4 | 13% |
| Student > Postgraduate | 3 | 10% |
| Student > Bachelor | 3 | 10% |
| Other | 3 | 10% |
| Unknown | 7 | 23% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 13 | 43% |
| Nursing and Health Professions | 2 | 7% |
| Psychology | 2 | 7% |
| Biochemistry, Genetics and Molecular Biology | 1 | 3% |
| Business, Management and Accounting | 1 | 3% |
| Other | 3 | 10% |
| Unknown | 8 | 27% |